Cointime

GlycoMimetics

company

About

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

  • 51 - 100

Highlights

Total Funding Amount
$20.50M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$15.40M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$20.50M
GlycoMimetics has raised a total of $20.50M in funding over 2 rounds. Their latest funding was raised on Jun 23, 2006 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 23, 2006 Series B $15.40M 1 — — Detail
Aug 6, 2004 Series A $5.10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
GlycoMimetics is funded by 1 investors. Maryland Department of Business and Economic Development are the most recent investors.
Investor Name Lead Investor Funding Round
Maryland Department of Business and Economic Development — Series B
Cointime
Chủ Đề
Công Ty